Relapse of immune thrombocytopenia after receiving <scp>AstraZeneca</scp> coronavirus disease‐2019 vaccine: A case report-Reference-Cited by-同舟云学术

Relapse of immune thrombocytopenia after receiving AstraZeneca coronavirus disease‐2019 vaccine: A case report

Published:2023-09 Issue:9 Volume:11 Page:
ISSN:2050-0904
Container-title:Clinical Case Reports
language:en
Short-container-title:Clinical Case Reports

Author:

Seyedi Saba¹,Navid Shadan²,Saadatian Zahra³^ORCID

Affiliation:

1. Department of Medical Laboratory Sciences, School of Medicine Gonabad University of Medical Sciences Gonabad Iran

2. Department of Anatomy, Faculty of Medicine, Social Determinants of Health Research Center Gonabad University of Medical Sciences Gonabad Iran

3. Department of Physiology, Faculty of Medicine, Infectious Diseases Research Center Gonabad University of Medical Sciences Gonabad Iran

Abstract

Key Clinical MessageImmune thrombocytopenic purpura (ITP) is an autoimmune disease characterized by a low platelets count. In this paper, we present a case of ITP relapse in a 31‐year‐old Iranian woman as a potential complication of the AstraZeneca vaccine.

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccr3.7872

Reference21 articles.

1. Characteristics of SARS-CoV-2 and COVID-19

2. Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine

3. A Review of the Progress and Challenges of Developing a Vaccine for COVID-19

4. Gov.UK.Regulatory approval of COVID‐19 vaccines AstraZeneca. MHRA. Information for healthcare professionals and the public about the COVID‐19 vaccine AstraZeneca.2020. Last update 23 February 2021. [Accessed 26 February 2021.] Available from:https://www.gov.uk/government/publications/regulatory‐approval‐of‐covid‐19‐vaccine‐astrazeneca

5. Thrombocytopenia and Intracranial Venous Sinus Thrombosis after “COVID-19 Vaccine AstraZeneca” Exposure

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Azd-1222;Reactions Weekly;2023-10-07